Breakthrough in Spinal Cord Injury Treatment: Bioinformatics Unveils Regenerative Therapy

In a significant development for spinal cord injury treatment, researchers at the University of California San Diego have identified a regenerative therapy using a combination of bioinformatics and cell culture techniques. Their approach pinpointed the drug Thiorphan as a potential candidate for treating spinal cord injuries, a condition notoriously difficult to study in the lab. Thiorphan, previously tested in humans for non-neurological conditions, showed promise in increasing neurite outgrowth in adult human brain cells and improving hand function in rats with spinal cord injuries.

Key Takeaways:

• Researchers at the University of California San Diego used bioinformatics to identify Thiorphan as a top candidate for treating spinal cord injuries, a condition previously difficult to study.
• Thiorphan, a drug previously tested in humans for non-neurological conditions, was found to increase neurite outgrowth in adult human brain cells and improve hand function in rats with spinal cord injuries.
• The researchers successfully cultured adult human brain cells in large numbers, a significant achievement in neuroregeneration research.
• The study's lead author, Erna van Niekerk, Ph.D., stated that the convergence of gene sequencing, computational bioinformatics, and cell culture identified a potentially useful treatment that might have taken decades to develop.
• The identification of Thiorphan has the potential to accelerate its advancement into clinical trials for spinal cord injuries.
• The study's authors, including Dr. Mark H. Tuszynski, M.D., emphasized the importance of culturing adult brain cells for testing new drugs and gene therapies for neurological disorders.

Statistics:

• 50% increase in recovery of hand function in rats treated with Thiorphan alone compared to untreated animals.
• 50% improvement in hand function in rats treated with Thiorphan combined with neural stem cell implant.
• Thiorphan has already undergone safety testing in humans, potentially speeding its advancement into clinical trials for spinal cord injuries.

Sources:

• University of California San Diego, "Bioinformatics Uncovers Regenerative Therapy for Spinal Cord Injury" (accessed October 29, 2022).
• van Niekerk, E., et al. "Novel regenerative therapy for spinal cord injury using a convergence of technologies." Nature (2022).